Live Breaking News & Updates on Peterc Taylor

Stay updated with breaking news from Peterc taylor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Peter C Taylor, PhD: Complexities of Treatment and Unmet Needs in Rheumatoid Arthritis

Peter C Taylor, PhD, discusses the current treatment landscape in rheumatoid arthritis and the unmet needs of this patient population. ....

Peterc Taylor , Norman Collisson , University Of Oxford , Musculoskeletal Sciences ,

Janssen's antibody drug shows phase 2 potential in rheumatoid arthritis

The proof-of-concept trial, dubbed IRIS-RA, is the first to investigate a treatment for rheumatoid arthritis that blocks a protein called neonatal Fc receptor (FcRn).


The antibody drug nipocalimab, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, has shown early promise for treating rheumatoid arthritis (RA) in a phase 2a trial. ....

Peterc Taylor , Norman Collisson , University Of Oxford , Momenta Pharmaceuticals , American College Of Rheumatology , Disease Activity Score , American College , Area Lead , Ludovic De Beaucoudrey , Drug Adminstration , Bio Developments , Antibody Drug Conjugates , Cell Amp Gene Therapies , Ohnson Amp Johnson , Rheumatoid Arthritis , Phase 2 , Clinical Trial ,